Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.230
+0.010 (0.82%)
At close: Aug 25, 2026, 4:00 PM EDT
1.230
0.00 (0.00%)
Pre-market: Aug 26, 2026, 6:45 AM EDT
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $166.13K in the quarter ending June 30, 2026, with 1.98% growth. This brings the company's revenue in the last twelve months to $721.39K, down -28.12% year-over-year. In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%.
Revenue (ttm)
$721.39K
Revenue Growth
-28.12%
P/S Ratio
10.66
Revenue / Employee
$6,273
Employees
115
Market Cap
7.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 622.49K | -3.29M | -84.10% |
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 10.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 4.22M |
| IceCure Medical | 3.95M |
| VolitionRx | 2.46M |
| Sintx Technologies | 1.33M |
| Nexalin Technology | 217.16K |
CODX News
- 1 day ago - Co-Diagnostics files to sell 3.4M shares of common stock for holders - TheFly
- 1 day ago - Co-Diagnostics Registration statement: Registration filing - Filings
- 7 days ago - Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event - PRNewsWire
- 12 days ago - Co-Diagnostics Earnings Call Transcript: Q2 2026 - Transcripts
- 12 days ago - Co-Diagnostics Earnings release: Q2 2026 - Filings
- 12 days ago - Co-Diagnostics Quarterly report: Q2 2026 - Filings
- 12 days ago - Co-Diagnostics Reports Second Quarter 2026 Financial Results - PRNewsWire
- 19 days ago - Co-Diagnostics submits FDA 510(k) premarket notification for Co-Dx PCR Flu test - TheFly